http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
ANZ Innovators Alimetry and The Clinician Among Five Winners In Medtronic APAC Innovation Challenge
-
Medtronic announces first patient implants of investigational implantable tibial neuromodulation therapy for bladder incontinence
-
Medtronic survey finds pandemic creating far-reaching and negative impacts on those with chronic back or leg pain
-
Medtronic appoints new Operating Unit Presidents
-
Medtronic (MDT) Reports US Trial of GI Genius Shows 50% Reduction in Missed Colorectal Polyps with AI Technology VS Standard Colonoscopy
-
First U.S. trial using GI Genius™ intelligent endoscopy module shows 50% reduction in missed colorectal polyps with artificial intelligence (AI) technology versus standard colonoscopy
-
Medtronic (MDT) Enters Contract with Vizient for Touch Surgery Enterprise
-
Medtronic announces contract with Vizient for Touch Surgery™ Enterprise
-
Medtronic announces cash dividend for fourth quarter of fiscal year 2022
-
Medtronic Executive Vice President and CFO to speak at Cowen healthcare conference
-
Medtronic announces launch of NuVent™ Eustachian tube dilation balloon
-
Cloud DX and Medtronic Sign First Contract with Ontario Hospital
-
Medtronic (MDT) receives FDA approval for InterStim X system
-
Medtronic receives FDA approval for InterStim X™ system, the next generation of the most personalized sacral nerve stimulation therapy for bladder and bowel control
-
Medtronic to provide underserved communities with artificial intelligence (AI)-assisted colonoscopy technology through Health Equity Assistance Program for colon cancer screening
-
Medtronic reports third quarter fiscal 2022 financial results
-
Medtronic (MDT) receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition
-
Medtronic receives FDA expanded approval for cardiac cryoablation catheters for pediatric treatment of a common heart rhythm condition
-
Medtronic to announce financial results for its third quarter of fiscal year 2022
-
Medtronic (MDT) Performs First Procedure with Hugo Robotic-Assisted Surgery System in Europe
-
Medtronic announces first procedure in Europe with Hugo™ robotic-assisted surgery system
-
Medtronic (MDT) announces FDA approval of spinal cord stimulation therapy for treating chronic pain resulting from diabetic peripheral neuropathy
-
Medtronic announces FDA approval of spinal cord stimulation therapy for treating chronic pain resulting from diabetic peripheral neuropathy
-
Medtronic (MDT) Reports Study Showing Meaningful Pain Relief Using DTM Spinal Cord Stimulation Endurance Therapy
-
Medtronic announces results showing meaningful pain relief using DTM™ Spinal Cord Stimulation endurance therapy
-
Medtronic announces schedule for presentations at the 2022 North American Neuromodulation Society Meeting
-
Medtronic (MDT) Granted Japanese Approval for Micra AV Transcatheter Pacing System, Will Launch Later this Month
-
Medtronic announces regulatory approval and launch in Japan of Micra AV Transcatheter Pacing System
-
Medtronic (MDT) Announces Approval of the Evolut PRO TAVR System in China
-
Medtronic Announces Approval of the Evolut™ PRO TAVR System in China
-
Medtronic (MDT) Acquires Affera
-
Medtronic to Acquire Affera
-
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
-
Medtronic (MDT) announces CMS expands diabetes Medicare coverage to include CGMs that integrate with Medtronic insulin pumps
-
CMS expands diabetes Medicare coverage to include CGMs that integrate with Medtronic insulin pumps
-
Medtronic announces two executive committee changes
-
Virtua Health and Medtronic Share Plans to Reimagine Traditional Health Care Models
-
Medtronic INVOS™ 7100 Cerebral/Somatic Oximetry System receives 510(k) clearance for pediatric indications
-
New study finds procedures treating spinal fractures associated with reduction in opioid use and decreased payer costs
-
Medtronic announces cash dividend for third quarter of fiscal year 2022
-
Medtronic Reports Second Quarter Fiscal 2022 Financial Results
-
Medtronic (MDT) announces 510(k) clearance for PillCam Small Bowel 3 @HOME endoscopy procedure
-
Medtronic announces 510(k) clearance for PillCam™ Small Bowel 3 @HOME endoscopy procedure
-
Medtronic taps top digital and healthcare technology leaders to drive company transformation
-
Medtronic named to the Dow Jones Sustainability World Index
-
Medtronic to announce financial results for its second quarter of fiscal year 2022
-
Medtronic announces 2045 net zero emissions ambition to combat climate change
-
Medtronic (MDT) Reports Early Data for Intrepid Transcatheter Mitral Valve Replacement System Using new Transfermoral Delivery
-
Medtronic announces early data for the Intrepid™ transcatheter mitral valve replacement (TMVR) system using new transfemoral delivery system
-
Medtronic's (MDT) TAVR platform Shows Excellent Long-Term Performance at Five Yeats in in SURTAVI Trial

